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One of the fundamental problems of modern 
biochemistry is the study of the chemical structure 
and the functioning of biological membranes, which 
play a dominating part in regulation of the molecular 
and ionic transport between the cell and its environ- 
ment. It would be no exaggeration to say that the 
progress achieved in latter years towards our under- 
standing of phenomena associated with transmem- 
brane ion transport is in one way or another connected 
with the application of antibiotic ionophores as tools 
for study of these phenomena. The successful use of 
such ionophores, forming complexes with alkali (or 
alkaline earth) metal ions and selectively inducing 
membrane permeability towards the complexed ion, 
has in turn stimulated the impetuous development of 
the chemistry of these unique bio-regulators. 
I shall first discuss the ‘prime’ ionophore, valino- 
mycin, and its numerous analogs, tracing the relation 
between the physicochemical properties of its various 
spatial forms and its behavior in the individual stages 
of the transmembrane ion transport process. Then I 
shall touch upon some new findings in the series of 
enniatin ionophores which have convinced us that 
we have a new type of transmembrane ion carriers, 
functioning in the form of bi- or trimolecular combi- 
nations. 
* Delivered in Austria, Federal Republic of Germany and 
Bulgaria. 
All correspondence to be sent to: Prof. Yu. A. Ovchinnikov, 
Shemyakin Institute of Bioorganic Chemistry, USSR Academy 
of Sciences, UI. Vavilova 32, Moscow 117-312, USSR. 
Valinomych 
The study of valinomycin antibiotics in our labora- 
tory took on a number of directions. On the one 
hand, the mode of action of valinomycin (fig. 1) and 
some of its analogs on lipid bilayers was investigated. 
We consider such bilayers as prototypes of the lipid 
zones of biological membrane systems. On the other 
hand, the synthesis of new valinomycin analogs and 
elucidation of their spectral characteristics was con- 
tinued, the accumulated data serving as basis for 
elucidating the conformational states of the free and 
alkali metal complexed valinomycins. Finally, a 
parallel. study was undertaken of the biological action 
of the valinomycins on bacteria and mitochondria. 
Fig. 1. Valinomycin (I). 
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Fig. 2. Ion transport model through phospholipid bilayers 
in the presence of valinomycin cyclodepsipeptides. 
The biophysical studies led to a model for the 
induced ion conductivity shown on fig. 2 [ 1,2] . First 
the ion becomes fixed on the membrane surface by 
heterogeneously complexing with the embedded 
ionophore molecule. It is then taken up by a free 
ionophore from within the membrane, the complex 
cation being further transported by bulk diffusion 
along a potential gradient. Thus according to the 
model the membrane resistance can be represented as 
the sum of ‘bulk’ and ‘boundary’ resistances, the 
former depending upon the concentration and mobili- 
ties of the complexes within the membrane and the 
latter, upon the rates of the heterogeneous complexing 
reaction, the surface to bulk potassium ion exchange 
and the intramembranal free cyclodepsipeptide flow. 
It turned out that Nature has built the molecule of 
this antibiotic to such perfection that all these stages 
have very similar rates. 
The behavior of valinomycin could also have been 
described by a similar model, as was done by Stark and 
Benz [3] in 197 1. However, structural peculiarities 
of the valinomycin analogs (XXVII and XL, see 
below) caused them considerable sluggishness at one 
or another of the transmembrane transporting stages 
which were thereby brought to light and thus includ- 
ed in our model. 
We aim to continue our studies on the behavior 
of valinomycin on artificial membranes, making use 
of the recently synthesized spin- and fluorescence- 
Table 1 
Leakage of K’ from lecithin liposomes in the presence of 
lo-’ M valinomycin and its derivatives II and III 
Compound Leakage of K’, in % of the % of valino- 
initial KNO, content, after mycin activity 
5 min at 25°C 
Valinomycin (I) 40.0 100 
II 44.0 110 
III 32.0 80 
labeled derivatives II and III [4] , which turned out 
practically identical to valinomycin in their ability to 
transport potassium ions across lecithin micelles 
(table 1). 
It follows from our model that for effective 
ionophore functioning a molecule of the valinomycin 
group must meet the following requirements; i ) ability 
to form sufficiently stable K’ complexes; ii) ability to 
partition between the surface and the internal zone 
of the membrane, i.e. possession of both lipophilicity 
and surface active properties; iii) sufficient lipophili- 
city of the K’ complex for it to be able to pass 
through the internal zone of the membrane; iv) suf- 
ficiently rapid exchange of the potassium ion be- 
tween two ionophore molecules. 
The 36-membered depsipeptide chain of valinomy- 
tin has a wealth of conformational possibilities. In 
non-polar media it assumes a compact symmetric (C,) 
structure (form A on fig. 3a), with the amide CO and 
NH groups forming an intra molecular hexa hydrogen- 
bonded ‘bracelet’. The ester carbonyls point away 
from the symmetry axis; all twelve alkyl side chains 
are situated on the molecular surface. In solvents of 
medium polarity a flatter structure with three 
hydrogen bonds, so-called ‘propeller’, (form B, see 
fig. 3b) is predominant. Its interior comprises a 
hydrophobic nucleus of three D-valine isopropyl 
groups and three lactic acid methyls. This is surround- 
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ed by the depsipeptide chain with the polar amide 
and ester groups. We consider it very likely that in the 
internal regions of the membrane, valinomycin assum- 
es conformation A and on its surface, conformation 
B. In polar media, including water, valinomycin is in 
the form of an equilibrium mixture of a large number 
of non-hydrogen bonded energetically similar confor- 
mers. Grell et al. [5,6] showed that several more 
conformers, apparently intermediate betw,een forms 
A, B and C, can exist in solution. 
Interestingly the crystalline state of valinomycin 
has a completely different conformation (fig. 4) 
despite recrystallization of the X-ray specimen from 
isooctane, i.e. from a solution where form A is predo- 
minant [7,8]. The structure observed has a pseudo 
symmetry center. In the crystal, all NH groups form 
hydrogen bonds, four with amide carbonyls and the 
remaining two with ester carbonyls. The nonequival- 
ence of the amide and ester carbonyls in crystalline 
valinomycin is distinctly manifested in both its IR 
spectrum (fig. 5) and Raman spectrum [9]. For com- 
parison fig. 6 gives the IR spectra of valinomycin in 
nonpolar solvents, where one can see the absence 
oC @JO ON----H-bond 
Fig. 4. Conformation of crystalline valinomycin. M and M’, 
P and P’, R and R’ are ester carbonyl oxygens arranged about 
a pseudo symmetry center; Q and Q’ are non-H-bonded 
amide oxygens, 1 and 2 - H-bonds of the 5 -+ 1 type. Arrows 
mark the direction of Q and Q’ displacement after rearrange 
ment of the crystalline conformer into the complexed form. 
OC 00 @ No H-bond 
Fig. 3. Conformation of valinomycin in (a) non-polar sol- 
vents, (b) solvents of medium polarity and (c) on com- 
plexation with KY 
3 
Volume 44, number 1 FEBS LETTERS August 1974 
gj 
1539 
1 
cm-l 
Fig. 5. Infra red spectrum of crystalline valinomycin. 
Fig. 6. Infra red spectra of valinomycin in non-polar solvents ‘(-- C, H, 6. . . . CC&, - - - CHCl, ). 
of any signs of splitting in the ester and amide carbonyl crystalline K’ complex [lo] . 
stretching bands (the lower wavelength shoulder of The diameter of the complex’s cavity (2.7-2.9 A) 
the amide I band is attributed to the presence of con- corresponds to the size of the potassium and rubidium 
formers containing less than six intramolecular hydro- ions. With cesium ions steric strain arises and the 
gen bonds). Valinomycin assumes a rigid conforma- stability constant falls [ 1 l] . 
tion in all solvents on complexing with K’. It has the The observed structural characteristics also clarify 
same hydrogen bond sequence as in form A, but its the high K/Na complexing selectivity of valinomycin: 
ester carbonyls are now turned inwards, forming 6 owing to the rigidity of the bracelet, it is unable to 
ion-dipole bonds with the centrally situated cation augment the efficiency of the ion-dipole interaction 
(fig. 3~). The latter is effectively screened from inter- with Na+such as to compensate the considerably 
action with the solvent and the anion by the depsi- higher Na’ than K’ solvation energy [ 121. 
peptide skeleton and the pendant side chains. The On the basis of all the above said one can rational- 
molecular surface of the complex thus consists mainly ize the complexing capacity of all the known synthetic 
of methyl and isopropyl groups, lending it its high analogs of valinomycin (tables 2-5). 
hydrophobicity. The same structure was found in the The K’ and Cs’ complexes of compound V com- 
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Fig. 7. Conformation of the Cs’ complex of ‘hexadecavalino- 
mycin’ (V). 
prising four (instead of the valinomycin three) tetra- 
depsipeptide fragments (‘hexadecavalinomycin’) 
are in the form of the hydrogen bonded bracelets 
with the depsipeptide chain folded much like that of 
the valinomycin complexes (judging from the CD, IR 
and NMR data) (fig. 7). The internal cavity in the 
complexing structure of V (diameter 4-5 A) is too 
large for effective ion-dipole interaction not only 
with K+ but even with Cs’; although, of course, the 
latter makes a better fit, explaining the preferential 
Cs+ complexation of ‘hexadecavalinomycin’ in solu- 
tion (table 2). 
Recently we have shown that despite the resultant 
steric strain ‘octa-valinomycin’ IV is also capable of 
complexing Na’ and K+ and that, in conformity with 
the size of the molecule, it manifests preference for 
Na’. The K’ complex of ‘octa-valinomycin’ is based 
on the same structural principles as the complex of 
the naturally occurring antibiotic (fig. 8a) whereas 
with Na’, the amide as well as the ester carbonyls take 
part in the interaction. Under such circumstances 
further weakening of the hydrogen bonds with their 
already unfavorable geometry takes place in the Na+ 
complex. Fig. 8b shows the conformation in which 
the cation is interacting only with the amide carbonyls. 
Most likely the sodium complex is in an equilibrium 
of structures represented on fig. 8a and 8b together 
Fig. 8. Conformation of the K+ complex of ‘octa-valinomycin’ 
IV (a) and the hypothetic conformation of its Na’ complex 
with all amide groups interacting with the cation (b). 
with intermediate conformers. 
The diastereomers of valinomycin form less stable 
complexes and are less potent antibiotics than the 
parent compound. From an energy standpoint the 
change in the amino and hydroxy acid configurations 
in the valinomycin K’ complex schematically shown 
in fig. 9 is to a first approximation equivalent to the 
appearance of new fragments with conformational 
maps with respect to # O”, 1+5 0”. As one can see 
from fig. 10 such changes are in all cases accompanied 
by enhanced non-bonding interaction energies: the 
energy of the valine and lactic acid fragments is less 
affected (1.9-4 kcal/mole), than that of the hydroxy- 
isovaleric acid fragments (by 10 kcal/mole) [ 131. It 
thus becomes clear why there is a successive diminu- 
tion of the stability constants with configurational 
change of one (compounds VI-IX, XV and XVIII), 
two (compounds XVI, XVII XIX and XX) and more 
(compounds X-XIII) residues, and why the complex 
is more sensitive to such change in the hydroxy- 
R2 
R2 
R2 
R2 
Fig. 9. Schematic representation of the change in configura- 
tion of the ammo (R,) and hydroxy acid (R,) residues in 
valinomycin -K’ complex (the dashed lines show the position 
of the isopropyl groups after the change in configuration). 
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Ac-L-Lac-NHMe Ac-L-Val-OMe Ac-D-HyIv-NHMe 
-180 -90 0 90 18t 
_ Ac-L-Val-OMe Ac-D-Lac-NHMe Ac-D-Val-OMe 
--. 
f-180 -90 0 '-90 
I 
180 ' -180 -90 0 90 180' 
-180 -90 0 90 leb -180 -90 0 90 180' -180 -90 0 90 180' -180 -90 0 90 
Ac-L-Hylv-NHMe 
Fig. 10. Conformational maps of the enantiomeric amino and hydroxy fragments of valinomycin. Dark circles - coordinates of the 
respective fragments of the valinomycin - K+ complex (upper row) and of its diastereomers (lower row). 
isovaleryl moiety (compounds IX, XII and XVIII-XX). 
Of considerable interest is the substitution of 
amide and ester groups in valinomycin by related 
groupings. On amide for ester substitution a hydrogen 
bond is lost, giving rise to a ca. 4 kcal . mole-’ 
energy loss (table 4, fig. 11). It is just such an effect 
(decrease in -AF from 8.6 to 4.7 kcal . mole-‘) 
that is observed in compound XXIV. In this case, 
modification of the antibiotic did not affect the other 
five H-bonds and the arrangement of carbonyl oxygens 
about the cation. If, however, the amide group is sub- 
stituted by an N-methyl amide group (fig. 1 l), not only 
is one of the hydrogen bonding protons lost, but the 
formation of neighbouring hydrogen bonds is 
sterically hindered, and the resultant analog (com- 
pound XXV) is even a weaker complexone, if at all 
(table 4). On the other hand, substitutions of the 
type L-Lac + L-Ala and D-HyIv + D-Val (compounds 
XXII, XXIII and XXVI) (table 4, fig. 12) retain the 
complexing properties; for the hydrogen bonding 
system is unaffected and the carbonyl groups are free 
to participate in the ion-dipole interaction. These 
analogs also show high antibacterial activity. 
Analogs with modified aliphatic side chain struc- 
-CONH- A -coo- w -CONCH3- 
Fig. 11. Schematic representation of the replacement of amide groups by ester or N-methyl amide groups in the valinomycin . K’ 
complex. 
10 
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-coo- _- -CONH- - -CON-Cl-+ 
Fig. 12. Schematic representation of the exchange of ester by amide or N-methylamide groups in the valinomycin - K’ complex 
(the substituted atoms are designated by dark circles). 
tures (table 5) are as a rule good complexones. In 
cases where a decrease in the free energy of complexa- 
tion is observed (e.g. compounds XXX and XXXIII) 
it is apparently due to enhanced conformational 
flexibility of the original depsipeptides rather than 
steric strain in the complex. In other words, here there 
is more probably a decrease in free energy on the left 
hand side of the equilibrium. 
macrocycle + K’ f (macrocycle . K)+ 
than an increase on the right hand side. 
(la 
However, despite the similarity in stability of the 
complexes of this series of compounds and those of 
valinomycin in ethanol, they can differ considerably 
from the latter in other parameters and, therefore, in 
their behavior in membrane systems. The best elucid- 
ated from this aspect is compound XL [1,2,14,15]. 
In nonpolar solvents and in the complexed state it is 
conformationally very similar to valinomycin. How- 
ever in solvents of medium polarity it manifests no 
signs of forming structure B, to the peculiarities of 
which we ascribe the high surface activity of valinomy- 
tin. In conformity with this analog XL monolayers 
are less stable than those of valinomycin in the air- 
water interface and also display a lesser tendency to 
penetrate the lecithin monolayer. 
A distinctive feature of the molecular structure of 
the K’-valinomycin complex is the effective screening 
of the central cation from the solvent, this being 
partly due to hanging of the valine isopropyl groups 
over the openings of the ‘cylinder’ formed by the 
depsipeptide skeleton. A notably different behavior 
is exhibited by the K’.XL complex: as can be seen 
in fig. 13, in the upper part of the complex it is the 
a b 
Fig. 13. Schematic drawing of the K’ complexes of valinomy- 
tin (al and its analog XL (b) on the membrane surface. 
alanyl methyls instead of the valyl isopropyl groups 
which cover the cation, with a correspondingly lower 
screening effect. As a result, the centrally located 
ion can now engage in ion-dipole interaction also 
with the solvent. The energy of this interaction 
provides for the enhanced stability of the K’ com- 
plex of analog XL, and for a tendency to enlarge 
the difference in free energies of complexation of 
valinomycin and analog XL with increasing solvent 
polarity or on the air-water interface (table 6). 
Table 6 
Stability constants (K, 1 X mole-‘) of the K+ complexes of valinomycin (I) and its 
analogs XXVII and XL in different solvents at 25°C. 
Compound EtOH 42 mol% 32 mol% H,O Air-water 
EtOH + EtOH + (extrapo- interface 
58 mol% 68 mol% lated values) 
Hz0 Hz0 
I 2.0 x lo6 500 100 0.25 1 
XXVII 10’ 1100 3900 100 - 
XL 2.6 x lo6 1400 100 6 3 
11 
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a b 
-90 0 90 
d ‘aoo 0 
-90 0 go ‘so’ 0 
Fig. 14. Conformational maps of Ac-D-Val-OMe (a), Ac-L- 
La-NHMe (b), Ac-D-Ala-NMe, (c)and Ac-L-MeAla- 
NHMe (d). Dark circles indicate coordinates of the correspond- 
ing residues in the form A of valinomycin, triangles - in the 
form B, and squares - in the K+ complex. 
Analog XL behaves differently from valinomycin 
on bilayers in that under certain conditions the rate 
of its K’ ion transport is limited by the flux of free 
cyclodepsipeptide molecules from within the mem- 
brane [ 1,2] . 
Thus our structural studies have shed considerable 
light on the molecular basis of the functioning of 
valinomycin cyclodepsipeptides in membranes and 
laid the grounds for the preparation of new, biologi- 
cally active compounds with predetermined proper- 
ties. 
A striking illustration of the potentialities of this 
approach serves our results with a new valinomycin 
analog, compound XXVII in which L-N-methylalanine 
residues are substituted for the L-lactic acid residues. 
Analysis of the corresponding conformational maps 
of Ac-D-Ala-N(CH,)zt and Ac-L-MeAla-NHMe 
t The conformational map of a more appropriate model, 
AC-D-V&N(CH,), has not been described in the litera- 
ture. Experimental data [ 161 indicate a relatively lower 
stability for the conformation of this compound with 
0 -60”) ic, -60” ; in all the rest, the conformational maps 
for AC-D-Val-N(CH,), and Ac-D-Ala-N(CH,), are 
quite similar. 
(fig. 14) [ 171 (instead of the valinomycinic Ac-D- 
Val-OMe and Ac-L-Lac-NHMe) showed that the 
@ and $ coordinates of the K’ complex of valino- 
mycin are close to their allowed regions, i.e. the for- 
mation of an analog XXVII complex should not meet 
with serious steric obstacles. However, compound 
XXVII has strictly limited non-complexed conforma- 
tional variability. For instance, the @ and JI parameters 
of the D-valine residues in the propeller conformation 
lie in the sterically prohibited region (fig. 14~). From 
this it follows that the free energies for the right 
hand side of the system represented by Eq. (1) should 
not differ in the case of valinomycin and analog 
XXVII, whereas the free energies for the left hand 
side are higher for compound XXVII. On this basis 
we expected it to display a high complexing activity. 
In fact, as shown by conductiometric measurements 
the K+ complex of compound XXVII has a ‘record 
stability constant, exceeding by at least l-2 orders 
of magnitude that of any other cyclodepsipeptide 
of the valinomycin series (tables 2-6). Apparently 
the analog obtained by Gisin and Merrifield in which 
the hydroxy acids are replaced by L- and D-proline 
residues has similar properties [ 181. 
The steric hindrances to introduction of an N- 
methyl group lead not only to enhanced stability of 
the K+complex, but also to lower rates of the ex- 
change reaction (Eq. 2): 
macrocycle* t macrocycle . K' f macrocycle* . 
K+ t macrocycle (2) 
As a result, in bilayer experiments, the rate of 
transition of the ion from the surface to the interior 
is lowered, making possible detection of this stage but 
this circumstance also lowers the ionophoric efficien- 
cy of analog XXVII. We have here a good illustration 
of why modification of the valinomycin structure 
in a way that would have accelerated all stages of the 
transmembrane ion transport is an exceptionally diffi- 
cult and still unresolved problem. 
Enniatins 
Like valinomycin the enniatin antibiotics (fig. 15) 
are of high structural flexibility. Two basic forms 
are known for enniatin B (fig. 16), viz., form N, 
12 
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R 
I Enniattn A - CH(CH,)C,H, 
II Enntatin B - CH (CH,), 
Ill Enntattn C - CH,CH(CH,), 
IV Beauverm - CH,C,H, 
Fig. 15. Antibiotics of the enniatin group. 
predominant in non-polar media and form P, found 
in polar media and in the crystalline state [23]. 
Both in solution and the crystalline state enniatins 
form equimolar complexes with alkali metal ions. 
These have been well elucidated [5,19,20,24-28). 
The complex structures (fig. 17) resemble discs of 
which the cations occupy the centers; the external 
Fig. 17. Conformation of the (enniatin B) . K* complex. 
boundaries are highly lipophilic. As in the case of the 
valinomycin complexes, the ion is held in the cavity 
by ion-dipole interaction with six carbonyl ligands. 
The conformational lability of the enniatins allows 
them to ‘fit’ the cavity to the complexing ion, 
leading to low complexing selectivity [5,24,25,27]. 
Alkali ion transport across membranes by the en- 
niatin ionophores has been studied much less extensi- 
vely than that of valinomycin [24,29-32,361. It had 
been taken for granted by analogy with valinomycin 
that the transport is effected by 1: 1 complexes. Our 
new results show that actually it is more complicated. 
Analysis of the NMR spectra of enniatin B (initial 
concentration cO) titrated by alkali salts showed that 
an increase in salt concentration (b,) and formation 
1 2 3 L 5 6 34 56 
Q, 89 -118 154 73 -58 -133 cb :4 -Ii3 74-103 74 -103 
y -109 92 32 -55-92 140 ‘j’ -136 17l -136 171 -136 171 
N P 
Fig. 16. The principal conformations of enniatin B. 
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5.5 5.0 Ii.5 P.P.m 
Fig. 18. The C H-NMR signals of enniatin B in CD, OD 
(co = 4.44 lo-* M) for various concentrations of LiCl (b,). 
1) co/b, = 0.2; 2) c,/!r, = 0.66; 3) co/b, = 1.85; 4) co/b, = 
3.65; 5) co/b, = 5.40; 6) co/b, = 7.16. 
of complexes are accompanied by changes in the 
chemical shifts (A6) and the 3JcoH_cflH spin-spin 
coupling constants to a limiting value corresponding 
to complete complexation (figs. 18-20). As one can 
see from figs. 19 and 20, the shapes of the curves ti- 
depend upon the nature of the complex cation, In 
the case of Li+smooth A6 vs. ho/co curves are ob- 
tained the slopes of which are less than for the curves 
computed for a 1: 1 complex with an infinitely high 
stability constant (fig. 19). In contrast, when enniatin 
B interacts with K’ the A6 = f(be/ce) curves are 
steeper than the predicted curve in all the solvents 
tt The presence of a single averaged signal for the free and 
complexed forms of the macrocyclic compound in the 
respective regions of the NMR spectra is indicative of a 
high ion exchange rate: 
CDP.M + CDP* 2 CDP + CDP*.M (CDP = cyclodepsi- 
peptide) on the NMR time scale. A different spectral 
pattern, bearing evidence of slower exchange rates is 
observed for valinomycin [ 11,331 and antamanide 1341. 
studied (fig. 20). A similar phenomenon was observed 
when enniatin C was titrated with KNCS in CDaOD. 
This suggests that for the relatively high macrocycle 
concentration required in the NMR experiments, the 
equilibrium involves a significant amount of com- 
plexes with a higher than 1: 1 macrocycle . M+ ratio. 
Since in KNCS titration the experimental A6 vs. 
ho/co plots closely approximate those computed for 
2: 1 complexes whereas none of them is steeper, we 
assume that it is the 2: 1 complexes which are most 
probably formed. This is also supported by the non- 
monotonic change of the proton chemical shifts 
for enniatin B in CDsOD and a 1: 1 CDClJ-CDaCN 
mixture showing an extremum at approximately 
be/co = 0.5 (fig. 20b and c). The curves reach a 
plateau at be/co x 3 (fig. 20), which indicates that, 
with such excess salt, the 2: 1 complex practically 
completely changes to the 1: 1 complex. The different 
shape of the curves from that on fig. 20 is ascribed to 
the larger internal shifts between the corresponding 
proteins in the 2: 1 and 1: 1 complexes than in 
(CDa)2S0. Determination of the stability constant 
K2 for the 2: 1 complex on the basis of these data 
leads to values by l-2 orders of magnitude below 
K1 (i.e., ca. 10’ in ethanol since the K1 range from 
lo3 to lo4 [24]). 
CDP t CDP . M+@ (CDP)2.M+; Kz = [(CD%-M’l 
[CDP] [ CDP.M+] 
Comparison of the enniatin B titration curves in 
CDaOD with salts of various metals (figs. 19 and 20) 
suggests that the stabilities of the 2: 1 complexes 
decrease in the order K’ > Cs’> Na+, nc 2: 1 com- 
plexes being observed for Li’. It should be noted 
that the initial slopes of the experimental curves for 
the CsNCS titration of enniatin B have values be- 
tween those for the 2: 1 and 1: 1 complexes, i.e. bear 
evidence of the presence of 3: 2 complexes. The for- 
mation of such complexes is in accord with the 
results of bilayer experiments (see below). 
As may be inferred from the similarity of the 
14 
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, 
-1 
-2r 
-31 
i b 2 
Fig. 21. CD curves in CH,CN of (1) enniatin B, (2) 1:l 
(enniatin B) : K’ complex, c0 = 3.17 . 10e4 M, b,/c, = 4.5, 
and (3) 2: 1 (enniatin B) : K’ complex, c, = 3.44 . lo-’ M, 
b,/c, = 0.5. 
corresponding CD curves (fig. 21) the cyclodepsi- 
peptide conformation in the 2: 1 complexes is similar 
to that of the well-studied equimolecular complexes. 
All the results suggest hat the 2: 1 complexes are 
of a sandwich structure with ‘amide’ (fig. 22a), ‘ester’ 
(fig. 22b) and ‘mixed’ (fig. 22~) types of coordination 
t w . .. . $ % 
a b E 
Fig. 22. Possible sandwich complexes for the enniatin anti- 
biotics. e-amide oxygen; o-ester carbonyl oxygen. 
a b 
Fig. 23. Possible conformations of the 2: 1 (a) and 3: 2 (b) 
complexes. 
The last two are the least probable because of spatial 
hindrance by the N-methyl groups. The ‘amide’ type 
of sandwich is shown in fig. 23a. In the 3: 2 complexes 
the ligands are, apparently, both amide and ester 
carbonyl groups (fig. 23b). 
Undoubtedly, in the sandwich complexes the cation 
is more effectively screened from interaction with the 
solvent and anion than in the equimolecular com- 
plexes, thus suggesting the possible participation of the 
former in the transmembrane ion transport despite 
their low stability constants. To test this possibility, 
we studied the effect of enniatin B and beauvericin 
on the ionic conductivity of bimolecular lipid mem- 
branes. The results obtained are shown in fig. 24. 
First of all attention is drawn to the second power 
dependence of potassium conductivity on enniatin B 
concentration over a wide range of salt concentration 
(fig. 24a). This suggests that the event of potassium 
ion transfer across a membrane in fact involves two 
molecules of enniatin B. However, it was not certain 
whether the second power is not associated with other 
features of the transport mechanism. To clarify this 
matter we synthesized ‘bis-enniatin B’ - an analogue 
in which two depsipeptide rings are connected by a 
sufficiently long and flexible chain, that is, one which 
has the prerequisites for sandwich formation within 
a single ionophore molecule (fig. 2.5). If such an analog 
would display linear dependence of its concentration 
on the potassium conductivity of the membrane, the 
observed second power dependence for enniatin B 
could then in all probability be attributed to stoichio- 
17 
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Enniatln 6 
6. 
KCi,M 
9 
Beauvcricin 
M 
am 
Bis-..enniatm B ” 
7 6 5 6 5 
8 7 6 7 5 -lge. 
a b C 
Fig. 24. Biiayer membrane conductivities fg,) in the presence of enniatins. 
a b 
Fig. 25. ‘bis-Enniatin B’ (a) and the assumed structure of its equimolec~~ complex (b). 
metric factors. Such a linear dependence has indeed 
been observed (fig. 24~) lending support to the 
proposal that sandwich complexes are a functional 
form of enniatin ionophores. 
It should also be noted that the power of the co- 
dependence of the enniatin B-induced conductivity is 
lower for sodium salts and higher for cesium salts than 
for the potassium salts (fig. 24d). It seems that the 
main contribution to the Na’ conductivity is provided 
by a mecha~sm involving equ~olecular complexes, 
whereas for Cs* three antibiotic molecules are involv- 
ed in the transport. On the basis of the titration 
results, it may be assumed that the Cs’ complexes 
participating in the transport are of a 3:2 stoichiome- 
try. The high power of the co-dependence for the 
beauvericin-induced conductivity (fig. 24b) also sug 
18 
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Fig. 26. Ion transport 
wa 
through phospholipid bilayers in the presence of enniatin cyclodepsipeptides. 
I 
membrane 
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fi Id 
e 
gests formation of ‘club-sandwiches’ by this antibiotic. 
Analysis of the data obtained has led to the model 
of ionic conductivity induced by enniatins shown in 
fig. 26. It differs markedly from that for the action 
of valinomycin shown in fig. 2. As with valinomycin 
the enniatinic model involves heterogeneous binding 
of the ion by the ionophore molecule situated on 
the membrane. But then the resultant complex either 
migrates along the electric potential gradient or binds 
with free ionophore molecules to form double or 
triple ‘sandwich’ complexes capable of moving in the 
membrane under the influence of the electric field. 
It follows from this model that the membrane resis- 
tance can be represented as the sum of ‘boundary’ and 
‘bulk’ resistances. The former depends upon the rate 
of the heterogeneous complexing reaction, the latter 
upon the concentration and mobilities of the equimol- 
cular double and triple complexes within the mem- 
brane. 
In this way, the enniatin antibiotics have the unique 
possibility of selecting from several parallel routes for 
transmembrane ion transport that which is optimal 
from the standpoint of ion and antibiotic concentra- 
tions and also lipophilicity, mobility and stability of 
the different complexes. 
In the limiting case, when the ‘sandwiches’ are 
sufficiently large, one can visualize a channel mechanism 
of action of the enniatin antibiotics similar to that 
proposed for the antibiotic gramicidin A. Urry suggest- 
ed that this linear pentadecapeptide forms a helical 
dimer (fig. 27a) which spans the membrane from one 
side to the other. A cation entrapped in the cavity 
(fig. 27b) can interact with the amide carbonyls 
twisted somewhat in the direction of the helical axis. 
In other words the cavity can play the part of a ‘pore’ 
in the functioning of gramicidin A in membranes. It 
is as yet difficult to evaluate the reality of Urry’s 
hypothesis. Veatch and Blout, for instance, propose 
other structures for the gramicidin A dimers, built 
according to the double helix type and stabilized by 
means of numerous interchain H-bonds (private com- 
munication). However the idea of an ion conducting 
channel formed by a comparatively small peptide is 
very attractive. 
The results of the study of peptide ionophores 
clearly show the advantages of the approach describ- 
ed here to the mechanism of transmembrane ion 
transport. In a comparatively short time the use of the 
antibiotic ionophores and their synthetic analogs has 
yielded valuable information on the functioning of 
fundamentally different transmembrane ion transport 
systems from carrier complexones to specific ‘pores’. 
Such variegation notwithstanding, a single principle 
lies at the bottom of this phenomenon, namely, the 
ion binds to carbonyl ligands of the peptide (or pro- 
tein) by ion-dipole interaction, thereby becoming 
enclosed in a comparatively rigid envelope, which 
lends the interaction its ion specificity. The lipo- 
philic nature of the periphery of such a complex 
closing the ion provides the conditions for its ability 
to function within the membrane. It appears very 
logical that similar principles should form the basis 
19 
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a 
Fig. 27. Schematic 
b 
representation of the n6 (L D)- helix of gramicidin A (a). In fig. b the cation is shown migrating along the 
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